v3.25.3
Investments Accounted for Using the Equity Method - Summary of Key Items Which Have Not Been Audited (Details) - Associates and joint ventures
€ in Millions
6 Months Ended
Jun. 30, 2025
EUR (€)
Disclosure of transactions between related parties [line items]  
Net Sales and Other Revenues € 887 [1]
Net Income 24 [1]
Other Comprehensive Income (1)
Comprehensive Income 23
 Non-current assets 16,179
Current assets 2,937
Total assets 19,116
 Equity attributable to equity holders of OPAL JV Co 5,754
 Equity attributable to non-controlling interests 541
Total equity 6,295
Non Current Liabilities 11,039
Current Liabilities 1,782
Total liabilities 12,821
Total equity and liabilities € 19,116
[1] With effect from May 1, 2025, OPAL JV Co is accounted for using the equity method following the loss of control of Opella by Sanofi on April 30, 2025.